Table 2. The correlation of circulating miR-106a with clinicopathological factors in CCA patients.
| Low expression | High expression | p value | |
|---|---|---|---|
| Age (y) | |||
| ≲65 | 40 | 29 | 0.44 |
| >65 | 17 | 17 | |
| Gender | |||
| Male | 33 | 22 | 0.31 |
| Female | 24 | 24 | |
| Serum CA19-9 level (U/ml) | |||
| ≤37 | 9 | 8 | 0.83 |
| >37 | 48 | 38 | |
| Radical resection | |||
| Yes | 30 | 30 | 0.20 |
| No | 27 | 16 | |
| Well differentiation | |||
| Yes | 2 | 4 | 0.26* |
| No | 55 | 42 | |
| Lymph node metastasis | |||
| Yes | 39 | 6 | <0.01 |
| No | 18 | 40 | |
| Nerve invasion | |||
| Yes | 39 | 26 | 0.21 |
| No | 18 | 20 | |
| p53 | |||
| Positive | 22 | 15 | 0.53 |
| Negative | 35 | 31 | |
| MUC1 | |||
| Positive | 24 | 18 | 0.76 |
| Negative | 33 | 28 | |
*means result of Fisher exact test.